Principal Investigator
Ashish Shah
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20240773
Clinical Trial Summary
A Phase I/IIa Study to Evaluate the Efficacy of DB107-RRV (Formerly Toca 511), Administered to Subjects at Time of Resection and Intravenously Thereafter, in Combination with DB107-FC (Formerly Toca FC) and Radiation Therapy or DB107-FC, Temozolomide (TMZ) and Radiation Therapy in Patients with Newly Diagnosed High-Grade Glioma
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Neurological Cancer
Contact Information
Phone Number
305-243-2647